The 3rd case of nephrogenic adenoma in the urethral diverticulum of a female is reported herein. A short review of the literature is presented.
Introduction
Nephrogenic adenoma (NA) is an uncommon lesion of the urinary tract, whose etiology is still debated. Although the lesion can occur throughout the urinary tract, most of the reported cases were located in the bladder. As far as we know, only 2 cases of NA within the urethral diverticulum have been previously reported: 1 by Peterson and Matsumoto [13] , and 1 by Berger et al. [2] . The 3rd case report of the wo rid-wide literature is herein described. Case Report A 32-year-old woman was admitted for evaluation of dysuria, dispareunia and post-voiding dribbling of 4 years of duration. Vaginal examination revealed a sub-urethral tender mass, producing a scanty yellowish discharge from the urethral meatus when palpated. On urinalysis sterile pyuria was present. History included 2 pregnancies (2 and 4 years before) with normal delivery but no urinary tract infections. A positive pressure urethrogram ( fig. 1 ) confirmed the presumptive diagnosis of urethral diverticulum and a transvagi-nal diverticulectomy was performed. Histologic examination showed nephrogenic adenoma ( fig. 2A, B) . Nine months after surgery the patient is asymptomatic, uricul-tures are negative, and vaginal examination reveals a wellhealed vaginal wall. In our case there was neither a previous history of urinary tract infections nor urethral instrumentation; moreover, the location of the lesion could not be explained by embriologic remnants, and the patient denied immunosuppressive drugs assumption. In 5 of the reported cases, NA coexisted with a bladder neoplasm: 3 transitional cell carcinomas [2, 11] and 2 adenocarcinomas of the bladder [3, 9] . However, it is still uncertain whether the occurrence of an invasive lesion results from a malignant transformation of NA or the latter simply represents a concomitant lesion. Although the occurrence of mesonephric carcinoma of the urethra is rare [7] , a close clinical observation has to be planned in these patients in order to detect early symptoms or signs of malignancy.
